X0508 4 2026-03-10 0 0001477449 Teladoc Health, Inc. TDOC 0001347535 DIVITA CHARLES III C/O TELADOC HEALTH, INC., 155 E 44TH ST, SUITE 1700 NEW YORK NY 10017 1 1 0 0 CHIEF EXECUTIVE OFFICER 0 Common Stock 2026-03-10 4 M 0 39160 A 367022 D Common Stock 2026-03-10 4 M 0 25493 A 392515 D Common Stock 2026-03-11 4 S 0 27731 5.49 D 364784 D Restricted Stock Units 2026-03-10 4 M 0 39160 0 D Common Stock 39160 195803 D Performance Stock Units 2026-03-10 4 A 0 43703 0 A Common Stock 43703 43703 D Performance Stock Units 2026-03-10 4 M 0 25493 0 D Common Stock 25493 18210 D Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. On June 10, 2024, the reporting person was granted 469,924 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Each performance stock unit represents a contingent right to receive one share of TDOC common stock. Performance award amount determined based on metrics in respect of the issuer's 2025 financial results. The performance stock units vest as to seven-twelfths on March 10, 2026, with the remainder vesting in five substantially equal quarterly installments over the subsequent 15 months. On March 10, 2026, the reporting person earned 43,703 performance stock units, vesting seven-twelfths on March 10, 2026, with the remainder vesting in five substantially equal quarterly installments over the subsequent 15 months. /s/ Adam C. Vandervoort, Attorney-in-Fact 2026-03-12